The Environmental Protection Agency (EPA) has announced that it will cease quantifying the financial savings associated with healthcare expenditures and avoided premature deaths resulting from regulations targeting two highly dangerous air pollutants.
This policy shift directs the EPA’s regulatory efforts for fine particulate matter and ozone exclusively toward evaluating the economic burdens imposed on industries. It aligns with a comprehensive strategic pivot under President Donald Trump’s leadership, emphasizing pro-business policies that have involved rescinding numerous measures previously designed to protect public health, preserve environmental integrity, and mitigate climate change effects.
In a formal statement released late Monday, the agency reaffirmed its dedication to its foundational objectives of safeguarding human health and the environment. However, it clarified that it would refrain from assigning monetary values to health-related outcomes at this juncture. According to EPA spokeswoman Brigit Hirsch, the organization will persist in assessing compliance costs for businesses and advance its efforts to enhance the economic analysis frameworks for pollution control measures.
Advocates for environmental protection and public health have condemned this decision as a perilous neglect of the agency’s primary responsibilities.
John Walke, a senior attorney with the Natural Resources Defense Council, stated, “The EPA’s core mandate is to shield public health, not to disregard scientific evidence in order to dismantle vital clean air protections that prevent loss of life.” He described the alteration in health benefit valuation methods as “reckless, dangerous, and illegal,” emphasizing, “By acting as if tangible health advantages do not matter, the EPA aims to enable industries to pollute the atmosphere freely, leaving communities and families to bear the consequences through increased asthma episodes, cardiovascular conditions, and early mortality.”
This development in the EPA’s approach to health benefit assessments was initially covered by the New York Times.
Shift Reflects EPA’s Larger Strategic Reorientation
This decision emerges amid the Trump administration’s push to repeal a stringent regulation establishing rigorous limits on deadly soot pollution, contending that the Biden administration exceeded its authority in imposing stricter controls on emissions from vehicle tailpipes, industrial smokestacks, and various other sources.
In a November court submission, the EPA argued that the Biden-era regulation was implemented without adhering to the methodical, step-by-step procedures mandated by Congress, rendering it invalid.
The agency maintains its acknowledgment of the “clear and well-documented benefits” stemming from reductions in fine particulate matter, commonly referred to as PM 2.5, and ozone levels.
Hirsch elaborated in an email, “Choosing not to monetize these impacts does not imply disregarding or undervaluing their effects on human health.” She reiterated the agency’s steadfast commitment to prioritizing health protections.
Over the course of more than five decades since its establishment, both Republican and Democratic administrations have employed varying methodologies to place a dollar figure on the value of a human life within cost-benefit evaluations.
During former President Joe Biden’s tenure, the EPA projected that its proposed PM 2.5 regulation could avert as many as 4,500 premature deaths and 290,000 lost workdays by the year 2032. The analysis indicated that for each dollar invested in PM 2.5 mitigation, health-related returns could reach up to $77.
Nevertheless, the current Trump administration asserts that such projections are deceptive. The EPA contends that presenting precise figures without accompanying ranges or caveats misleads the public into assuming a level of certainty in monetizing PM 2.5 and ozone exposure effects that does not exist. In its economic impact assessment for the updated NOx regulation, the agency explained, “To correct this inaccuracy, the EPA will discontinue monetizing benefits from PM 2.5 and ozone. It will, however, continue to measure emission reductions until its modeling achieves sufficient reliability for accurate monetization.”
The EPA highlighted that the United States has achieved notable reductions in PM 2.5 and ozone levels since the year 2000.
Opponents Highlight Health Hazards of the Revised Methodology
Detractors argue that a recently finalized EPA rule, which adjusts emission thresholds for hazardous nitrogen oxide pollution from newly installed gas-fired turbines in power plants, exemplifies the perils inherent in this new evaluative framework.
Nitrogen oxide emissions, known as NOx, contribute to the formation of smog and soot, both of which pose severe risks to human health and are associated with critical cardiac and respiratory illnesses. The EPA’s finalized NOx rule, released on Monday, imposes far less stringent limits compared to a Biden administration proposal. For certain gas-fired facilities, it dilutes safeguards that have been in effect for the past 20 years.
Notably, this updated rule omits any estimation of the monetary worth of health improvements from curbing NOx and related pollutants under the Clean Air Act. Critics contend that this omission allows the EPA to overlook the financial significance of preserved lives, prevented hospitalizations, and avoided absences from work and school.
Noha Haggag, a lawyer with the Environmental Defense Fund, an advocacy organization focused on environmental issues, criticized the Trump-era EPA for “recklessly refusing to assign any economic value to shielding millions of Americans from nitrogen oxides pollution, despite overwhelming medical evidence linking it to asthma exacerbations, heart disease, and other grave health issues.”
Haggag further warned, “The EPA is exposing millions to unnecessary dangers when straightforward, effective strategies exist for establishing contemporary nationwide restrictions on nitrogen oxides emissions.”
